Insider Trades48 trades
| Date↓ | Side | Ticker↕ | Insider↕ | Role↕ | Shares↕ | Price↕ | Mkt Cap↕ | 52W High↕ | 52W Low↕ | Value↕ | % Chg↕ | Rule↕ | AI View↕ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 15, 2026 | Sell | MGNX | Beth Ann Smith | VP, Controller & Treasurer | 423 | $1.71 | $254.8M | -21.26% | +210.08% | $723.33 | -0.35% | — | — |
| Feb 15, 2026 | Sell | MGNX | Jeffrey Stuart Peters | Senior VP, GC, and Secretary | 5,147 | $1.71 | $254.8M | -21.26% | +210.08% | $8.8K | -2.44% | — | — |
| Feb 15, 2026 | Sell | MGNX | Thomas Spitznagel | Sr VP, Technical Ops | 5,520 | $1.71 | $254.8M | -21.26% | +210.08% | $9.4K | -2.52% | — | — |
| Feb 15, 2026 | Sell | MGNX | James Karrels | SVP and CFO | 5,790 | $1.71 | $254.8M | -21.26% | +210.08% | $9.9K | -1.50% | — | — |
| Feb 15, 2026 | Sell | MGNX | Eric Blasius Risser | President and CEO | 6,433 | $1.71 | $254.8M | -21.26% | +210.08% | $11.0K | -0.83% | — | — |
| Feb 15, 2026 | Sell | MGNX | Ezio Bonvini | Sr VP, Research & CSO | 6,433 | $1.71 | $254.8M | -21.26% | +210.08% | $11.0K | -1.73% | — | — |
| Feb 7, 2026 | Sell | MGNX | Beth Ann Smith | VP, Controller & Treasurer | 1,623 | $1.81 | $254.8M | -21.26% | +210.08% | $2.9K | -5.12% | — | — |
| Feb 7, 2026 | Sell | MGNX | Thomas Spitznagel | Sr VP, Technical Ops | 5,671 | $1.81 | $254.8M | -21.26% | +210.08% | $10.3K | -6.89% | — | — |
| Feb 7, 2026 | Sell | MGNX | Jeffrey Stuart Peters | Senior VP, GC, and Secretary | 5,791 | $1.81 | $254.8M | -21.26% | +210.08% | $10.5K | -8.63% | — | — |
| Feb 7, 2026 | Sell | MGNX | James Karrels | SVP and CFO | 6,306 | $1.81 | $254.8M | -21.26% | +210.08% | $11.4K | -1.51% | — | — |
| Feb 7, 2026 | Sell | MGNX | Eric Blasius Risser | President and CEO | 6,886 | $1.81 | $254.8M | -21.26% | +210.08% | $12.5K | -4.35% | — | — |
| Feb 7, 2026 | Sell | MGNX | Ezio Bonvini | Sr VP, Research & CSO | 7,014 | $1.81 | $254.8M | -21.26% | +210.08% | $12.7K | -2.37% | — | — |
| Feb 15, 2025 | Sell | MGNX | Beth Ann Smith | VP, Controller & Treasurer | 423 | $2.56 | $254.8M | -21.26% | +210.08% | $1.1K | -3.83% | — | — |
| Feb 15, 2025 | Sell | MGNX | Stephen L. Eck | Chief Medical Officer | 4,942 | $2.56 | $254.8M | -21.26% | +210.08% | $12.7K | -9.69% | — | — |
| Feb 15, 2025 | Sell | MGNX | Jeffrey Stuart Peters | Senior VP and General Counsel | 5,147 | $2.56 | $254.8M | -21.26% | +210.08% | $13.2K | -15.99% | — | — |
| Feb 15, 2025 | Sell | MGNX | Thomas Spitznagel | Sr VP, Technical Ops | 5,520 | $2.56 | $254.8M | -21.26% | +210.08% | $14.1K | -13.71% | — | — |
| Feb 15, 2025 | Sell | MGNX | James Karrels | SVP, CFO and Secretary | 5,790 | $2.56 | $254.8M | -21.26% | +210.08% | $14.8K | -2.79% | — | — |
| Feb 15, 2025 | Sell | MGNX | Eric Blasius Risser | Chief Operating Officer | 6,433 | $2.56 | $254.8M | -21.26% | +210.08% | $16.5K | -8.13% | — | — |
| Feb 8, 2025 | Sell | MGNX | Beth Ann Smith | VP, Controller & Treasurer | 612 | $2.60 | $254.8M | -21.26% | +210.08% | $1.6K | -0.91% | — | — |
| Feb 8, 2025 | Sell | MGNX | Stephen L. Eck | Chief Medical Officer | 3,312 | $2.60 | $254.8M | -21.26% | +210.08% | $8.6K | -1.89% | — | — |
| Feb 8, 2025 | Sell | MGNX | Jeffrey Stuart Peters | Senior VP and General Counsel | 3,475 | $2.60 | $254.8M | -21.26% | +210.08% | $9.0K | -2.32% | — | — |
| Feb 8, 2025 | Sell | MGNX | Thomas Spitznagel | Sr VP, Technical Ops | 3,727 | $2.60 | $254.8M | -21.26% | +210.08% | $9.7K | -2.35% | — | — |
| Feb 8, 2025 | Sell | MGNX | James Karrels | SVP, CFO and Secretary | 3,861 | $2.60 | $254.8M | -21.26% | +210.08% | $10.0K | -1.16% | — | — |
| Feb 8, 2025 | Sell | MGNX | Eric Blasius Risser | Chief Operating Officer | 4,311 | $2.60 | $254.8M | -21.26% | +210.08% | $11.2K | -2.03% | — | — |
| Feb 8, 2025 | Sell | MGNX | Ezio Bonvini | Sr VP, Research & CSO | 4,311 | $2.60 | $254.8M | -21.26% | +210.08% | $11.2K | -1.52% | — | — |
| Oct 7, 2024 | Sell | MGNX | Scott Koenig | President and CEO | 106,530 | $3.59 | $254.8M | -21.26% | +210.08% | $382.4K | +0.00% | — | — |
| Sep 23, 2024 | Sell | MGNX | Scott Koenig | President and CEO | 748,430 | $3.06 | $254.8M | -21.26% | +210.08% | $2.3M | +0.00% | — | — |
| Apr 4, 2024 | Sell | MGNX | Jeffrey Stuart Peters | Senior VP and General Counsel | 93,895 | $10.69 | $254.8M | -21.26% | +210.08% | $1.0M | -4.10% | 10b5-1 | — |
| Mar 6, 2024 | Sell | MGNX | Jeffrey Stuart Peters | Senior VP and General Counsel | 39,250 | $16.20 | $254.8M | -21.26% | +210.08% | $635.8K | +0.00% | — | — |
| Mar 4, 2024 | Sell | MGNX | Thomas Spitznagel | Sr VP, Technical Ops | 20,000 | $15.75 | $254.8M | -21.26% | +210.08% | $315.0K | +0.00% | 10b5-1 | — |
| Mar 4, 2024 | Sell | MGNX | James Karrels | SVP, CFO and Secretary | 30,000 | $20.50 | $254.8M | -21.26% | +210.08% | $615.0K | -14.89% | 10b5-1 | — |
| Mar 4, 2024 | Sell | MGNX | Eric Blasius Risser | Chief Operating Officer | 56,159 | $17.20 | $254.8M | -21.26% | +210.08% | $965.8K | -7.16% | 10b5-1 | — |
| Feb 26, 2024 | Sell | MGNX | Jeffrey Stuart Peters | Senior VP and General Counsel | 16,124 | $17.22 | $254.8M | -21.26% | +210.08% | $277.7K | -64.45% | 10b5-1 | — |
| Feb 22, 2024 | Sell | MGNX | Ezio Bonvini | Sr VP, Research & CSO | 9,366 | $17.11 | $254.8M | -21.26% | +210.08% | $160.3K | -8.49% | — | — |
| Feb 22, 2024 | Sell | MGNX | Jeffrey Stuart Peters | Senior VP and General Counsel | 10,126 | $17.11 | $254.8M | -21.26% | +210.08% | $173.3K | -28.81% | — | — |
| Feb 15, 2024 | Sell | MGNX | Lynn Cilinski | VP, Controller and Treasurer | 2,378 | $17.40 | $254.8M | -21.26% | +210.08% | $41.4K | -10.85% | — | — |
| Feb 15, 2024 | Sell | MGNX | Jeffrey Stuart Peters | Senior VP and General Counsel | 4,441 | $17.40 | $254.8M | -21.26% | +210.08% | $77.3K | -11.10% | — | — |
| Feb 15, 2024 | Sell | MGNX | Thomas Spitznagel | Sr VP, Technical Ops | 5,020 | $17.40 | $254.8M | -21.26% | +210.08% | $87.3K | -12.55% | — | — |
| Feb 15, 2024 | Sell | MGNX | James Karrels | SVP, CFO and Secretary | 5,327 | $17.40 | $254.8M | -21.26% | +210.08% | $92.7K | -2.25% | — | — |
| Feb 15, 2024 | Sell | MGNX | Ezio Bonvini | Sr VP, Research & CSO | 5,871 | $17.40 | $254.8M | -21.26% | +210.08% | $102.2K | -4.84% | — | — |
| Feb 15, 2024 | Sell | MGNX | Eric Blasius Risser | Chief Operating Officer | 5,879 | $17.40 | $254.8M | -21.26% | +210.08% | $102.3K | -5.64% | — | — |
| Feb 15, 2024 | Sell | MGNX | Stephen L. Eck | Chief Medical Officer | 6,872 | $17.40 | $254.8M | -21.26% | +210.08% | $119.6K | -13.74% | — | — |
| Feb 15, 2024 | Sell | MGNX | Scott Koenig | President and CEO | 14,349 | $17.40 | $254.8M | -21.26% | +210.08% | $249.7K | -1.22% | — | — |
| Feb 7, 2024 | Sell | MGNX | Ezio Bonvini | Sr VP, Research & CSO | 3,334 | $18.00 | $254.8M | -21.26% | +210.08% | $60.0K | -4.47% | — | — |
| Feb 5, 2024 | Sell | MGNX | Jeffrey Stuart Peters | Senior VP and General Counsel | 152,502 | $13.81 | $254.8M | -21.26% | +210.08% | $2.1M | +0.00% | 10b5-1 | — |
| Feb 1, 2024 | Sell | MGNX | Ezio Bonvini | Sr VP, Research & CSO | 13,316 | $15.00 | $254.8M | -21.26% | +210.08% | $199.7K | -15.13% | — | — |
| Jan 19, 2024 | Sell | MGNX | Ezio Bonvini | Sr VP, Research & CSO | 13,316 | $12.00 | $254.8M | -21.26% | +210.08% | $159.8K | -13.15% | — | — |
| Dec 20, 2023 | Sell | MGNX | Ezio Bonvini | Sr VP, Research & CSO | 18,880 | $10.08 | $254.8M | -21.26% | +210.08% | $190.3K | -15.71% | — | — |